284 related articles for article (PubMed ID: 22503741)
1. Design, synthesis and biological evaluation of novel chalcone derivatives as antitubulin agents.
Zhang H; Liu JJ; Sun J; Yang XH; Zhao TT; Lu X; Gong HB; Zhu HL
Bioorg Med Chem; 2012 May; 20(10):3212-8. PubMed ID: 22503741
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and molecular docking studies of 2,6-dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime derivatives as novel antitubulin agents.
Zhao TT; Lu X; Yang XH; Wang LM; Li X; Wang ZC; Gong HB; Zhu HL
Bioorg Med Chem; 2012 May; 20(10):3233-41. PubMed ID: 22512906
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents.
Qian Y; Zhang HJ; Lv PC; Zhu HL
Bioorg Med Chem; 2010 Dec; 18(23):8218-25. PubMed ID: 21036623
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents.
Ruan BF; Lu X; Tang JF; Wei Y; Wang XL; Zhang YB; Wang LS; Zhu HL
Bioorg Med Chem; 2011 Apr; 19(8):2688-95. PubMed ID: 21440448
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents.
Qian Y; Ma GY; Yang Y; Cheng K; Zheng QZ; Mao WJ; Shi L; Zhao J; Zhu HL
Bioorg Med Chem; 2010 Jun; 18(12):4310-6. PubMed ID: 20493717
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
Alswah M; Bayoumi AH; Elgamal K; Elmorsy A; Ihmaid S; Ahmed HEA
Molecules; 2017 Dec; 23(1):. PubMed ID: 29280968
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors.
Yin Y; Qiao F; Jiang LY; Wang SF; Sha S; Wu X; Lv PC; Zhu HL
Bioorg Med Chem; 2014 Aug; 22(15):4285-92. PubMed ID: 24916028
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents.
Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of novel N-γ-carboline arylsulfonamides as anticancer agents.
Chen J; Liu T; Wu R; Lou J; Cao J; Dong X; Yang B; He Q; Hu Y
Bioorg Med Chem; 2010 Dec; 18(24):8478-84. PubMed ID: 21067933
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors.
Zhang H; Lu X; Zhang LR; Liu JJ; Yang XH; Wang XM; Zhu HL
Bioorg Med Chem; 2012 Feb; 20(4):1411-6. PubMed ID: 22277588
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors.
Rahimzadeh Oskuei S; Mirzaei S; Reza Jafari-Nik M; Hadizadeh F; Eisvand F; Mosaffa F; Ghodsi R
Bioorg Chem; 2021 Jul; 112():104904. PubMed ID: 33933802
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and cytotoxic activity of certain novel chalcone analogous compounds.
El-Meligie S; Taher AT; Kamal AM; Youssef A
Eur J Med Chem; 2017 Jan; 126():52-60. PubMed ID: 27744186
[TBL] [Abstract][Full Text] [Related]
15. Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin.
Kim DY; Kim KH; Kim ND; Lee KY; Han CK; Yoon JH; Moon SK; Lee SS; Seong BL
J Med Chem; 2006 Sep; 49(19):5664-70. PubMed ID: 16970393
[TBL] [Abstract][Full Text] [Related]
16. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.
Nien CY; Chen YC; Kuo CC; Hsieh HP; Chang CY; Wu JS; Wu SY; Liou JP; Chang JY
J Med Chem; 2010 Mar; 53(5):2309-13. PubMed ID: 20148562
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation and molecular modeling of 1,3,4-thiadiazol-2-amide derivatives as novel antitubulin agents.
Li YJ; Qin YJ; Makawana JA; Wang YT; Zhang YQ; Zhang YL; Yang MR; Jiang AQ; Zhu HL
Bioorg Med Chem; 2014 Aug; 22(15):4312-22. PubMed ID: 24909678
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and 3D-QSAR studies of novel 5-phenyl-1H-pyrazol cinnamamide derivatives as novel antitubulin agents.
Wang SF; Yin Y; Zhang YL; Mi SW; Zhao MY; Lv PC; Wang BZ; Zhu HL
Eur J Med Chem; 2015 Mar; 93():291-9. PubMed ID: 25703297
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of phenstatin/isocombretastatin-chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers.
Kamal A; Kumar GB; Vishnuvardhan MV; Shaik AB; Reddy VS; Mahesh R; Sayeeda IB; Kapure JS
Org Biomol Chem; 2015 Apr; 13(13):3963-81. PubMed ID: 25721862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]